FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

4125411000001105: Zanamivir 5mg inhalation powder blisters with device 20 blister (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21865101000001111 Zanamivir 5mg inhalation powder blisters with device 20 blister (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21865201000001116 Zanamivir 5mg inhalation powder blisters with device 20 blister en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zanamivir 5mg inhalation powder blisters with device 20 blister Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zanamivir 5mg inhalation powder blisters with device 20 blister Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Zanamivir 5mg inhalation powder blisters with device 20 blister Is pack of Zanamivir 5mg/blister disks+disk inhaler false Inferred relationship Existential restriction modifier
Zanamivir 5mg inhalation powder blisters with device 20 blister Has active ingredient Zanamivir false Inferred relationship Existential restriction modifier
Zanamivir 5mg inhalation powder blisters with device 20 blister VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zanamivir 5mg inhalation powder blisters with device 20 blister VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zanamivir 5mg inhalation powder blisters with device 20 blister Has manufactured dose form Conventional release powder for inhalation false Inferred relationship Existential restriction modifier
Zanamivir 5mg inhalation powder blisters with device 20 blister Has VMP Zanamivir 5mg/blister disks+disk inhaler false Inferred relationship Existential restriction modifier
Zanamivir 5mg inhalation powder blisters with device 20 blister Has specific active ingredient Zanamivir true Inferred relationship Existential restriction modifier
Zanamivir 5mg inhalation powder blisters with device 20 blister Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Zanamivir 5mg inhalation powder blisters with device 20 blister Has VMP Zanamivir 5mg inhalation powder blisters with device false Inferred relationship Existential restriction modifier
Zanamivir 5mg inhalation powder blisters with device 20 blister Has VMP Zanamivir 5mg inhalation powder blisters with device true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Relenza 5mg inhalation powder blisters with Diskhaler (GlaxoSmithKline) 20 blister 5 x 1 disk (4 blisters) Is a True Zanamivir 5mg inhalation powder blisters with device 20 blister Inferred relationship Existential restriction modifier
Relenza 5mg inhalation powder blisters with Diskhaler (PI) (Dowelhurst Ltd) 20 blister Is a True Zanamivir 5mg inhalation powder blisters with device 20 blister Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start